Published in Eur J Biochem on February 01, 1998
Virulent Salmonella typhimurium has two periplasmic Cu, Zn-superoxide dismutases. Proc Natl Acad Sci U S A (1999) 2.44
Role of iron in Nramp1-mediated inhibition of mycobacterial growth. Infect Immun (1999) 1.24
A superoxide-hypersusceptible Salmonella enterica serovar Typhimurium mutant is attenuated but regains virulence in p47(phox-/-) mice. Infect Immun (2002) 0.93
Downregulation of protein kinase C-alpha enhances intracellular survival of Mycobacteria: role of PknG. BMC Microbiol (2009) 0.88
Regulation of Nramp1 mRNA stability by oxidants and protein kinase C in RAW264.7 macrophages expressing Nramp1(Gly169). Biochem J (2000) 0.84
Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell (1993) 6.99
Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect (1998) 6.08
Genetic regulation of resistance to intracellular pathogens. Nature (1982) 4.45
ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. J Virol (2002) 4.11
Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. J Immunol (1981) 3.95
The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J Exp Med (1995) 3.86
The unmet supportive care needs of patients with cancer. Supportive Care Review Group. Cancer (2000) 3.47
The specialist list in orthodontics: a postmortem. Br Dent J (2001) 3.20
Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother (1994) 3.02
Summarizing indices for comparison of cancer incidence data. Int J Cancer (1967) 2.80
Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell (1997) 2.64
Evaluation of an instrument to assess the needs of patients with cancer. Supportive Care Review Group. Cancer (2000) 2.37
Murine malaria: genetic control of resistance to Plasmodium chabaudi. Infect Immun (1982) 2.27
Immunopathology of BCG infection in genetically resistant and susceptible mouse strains. J Immunol (1982) 2.23
Genetic control of resistance to Listeria monocytogenes: regulation of leukocyte inflammatory responses by the Hc locus. J Immunol (1984) 2.19
Genetic linkage of resistance to Listeria monocytogenes with macrophage inflammatory responses. J Immunol (1981) 2.17
Differences in response among inbred mouse strains to infection with small doses of Mycobacterium bovis BCG. Infect Immun (1981) 2.16
Phenotypic expression of genetically-controlled natural resistance to Mycobacterium bovis (BCG). J Immunol (1984) 2.13
Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat Med (2001) 2.10
Resistance to Listeria monocytogenes in mice: genetic control by genes that are not linked to the H-2 complex. J Infect Dis (1979) 2.09
The Bcg/Ity/Lsh locus: genetic transfer of resistance to infections in C57BL/6J mice transgenic for the Nramp1 Gly169 allele. Infect Immun (1996) 2.02
Implication of phagosome-lysosome fusion in restriction of Mycobacterium avium growth in bone marrow macrophages from genetically resistant mice. Infect Immun (1993) 1.98
Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells. Mol Endocrinol (1996) 1.98
Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol (1999) 1.90
A BALB/c congenic strain of mice that carries a genetic locus (Ityr) controlling resistance to intracellular parasites. Infect Immun (1983) 1.86
Genetic regulation of early survival and cyst number after peroral Toxoplasma gondii infection of A x B/B x A recombinant inbred and B10 congenic mice. J Immunol (1989) 1.82
Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression. J Exp Med (1994) 1.82
Cellular mechanisms of genetically controlled host resistance to Mycobacterium bovis (BCG). J Immunol (1983) 1.81
Susceptibility to leprosy is linked to the human NRAMP1 gene. J Infect Dis (1998) 1.79
The effects of macrocyclic compounds on cation transport in sheep red cells and thin and thick lipid membranes. J Gen Physiol (1968) 1.64
Regulation of resistance to leprosy by chromosome 1 locus in the mouse. Immunogenetics (1984) 1.63
1alpha,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J Biol Chem (2001) 1.62
Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers. J Immunol (1998) 1.61
Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa. Infect Immun (1995) 1.61
Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products. J Immunol (1987) 1.60
Recombinant inbred mouse strains derived from A/J and C57BL/6J: a tool for the study of genetic mechanisms in host resistance to infection and malignancy. J Leukoc Biol (1984) 1.57
Cellular basis for genetically determined enhanced resistance of certain mouse strains to listeriosis. Infect Immun (1980) 1.57
Endobronchial inflammation following Pseudomonas aeruginosa infection in resistant and susceptible strains of mice. Infect Immun (1995) 1.57
Differential inhibition of IL-1 and TNF-alpha mRNA expression by agents which block second messenger pathways in murine macrophages. J Immunol (1988) 1.55
Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy. Eur J Cancer (1997) 1.55
Attenuation of gamma interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1. Infect Immun (1995) 1.54
A Th1-associated increase in tumor necrosis factor alpha expression in the spleen correlates with resistance to blood-stage malaria in mice. Infect Immun (1996) 1.52
Distinct H-2 complex control of mortality, and immune responses to tuberculosis infection in virgin and BCG-vaccinated mice. Clin Exp Immunol (1993) 1.52
Nephrotoxicity of gentamicin and tobramycin given once daily or continuously in dogs. J Antimicrob Chemother (1978) 1.50
Cloning and characterization of the murine toll-like receptor 5 (Tlr5) gene: sequence and mRNA expression studies in Salmonella-susceptible MOLF/Ei mice. Genomics (2000) 1.49
The Salmonella spvB virulence gene encodes an enzyme that ADP-ribosylates actin and destabilizes the cytoskeleton of eukaryotic cells. Mol Microbiol (2001) 1.45
Heterogeneity of hematopoietic cells immortalized by v-myc/v-raf recombinant retrovirus infection of bone marrow or fetal liver. J Natl Cancer Inst (1989) 1.44
The effect of valinomycin on potassium and sodium permeability of HK and LK sheep red cells. J Gen Physiol (1967) 1.44
Mucociliary clearance in patients with cystic fibrosis and in normal subjects. Am J Respir Crit Care Med (1994) 1.44
Lung disease in mice with cystic fibrosis. J Clin Invest (1997) 1.44
Susceptibility and resistance of inbred mice to Giardia muris. Infect Immun (1984) 1.44
Arachidonic acid metabolism by murine peritoneal macrophages infected with Leishmania donovani: in vitro evidence for parasite-induced alterations in cyclooxygenase and lipoxygenase pathways. J Immunol (1985) 1.43
Relapsing polychondritis: report of an unusual case and a review of the literature. Br J Radiol (1991) 1.43
Recombinant congenic strains derived from A/J and C57BL/6J: a tool for genetic dissection of complex traits. Genomics (2001) 1.42
Use of real-time PCR and fluorimetry to detect lamivudine resistance-associated mutations in hepatitis B virus. Antimicrob Agents Chemother (1999) 1.41
Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family. J Biol Chem (1994) 1.40
A Bayesian analysis of regression models with continuous errors with application to longitudinal studies. Stat Med (1997) 1.38
Susceptibility/resistance to mouse hepatitis virus strain 3 and macrophage procoagulant activity are genetically linked and controlled by two non-H-2-linked genes. J Immunol (1986) 1.37
Re-emerging syphilis in gay men: a case-control study of behavioural risk factors and HIV status. J Epidemiol Community Health (2002) 1.36
Regulation of host resistance to Mycobacterium intracellulare in vivo and in vitro by the Bcg gene. Immunogenetics (1989) 1.35
Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene. Am J Hum Genet (1995) 1.35
1alpha,25-dihydroxyvitamin D(3)-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex. J Exp Med (1999) 1.32
Two distinct regions in the 3' untranslated region of tumor necrosis factor alpha mRNA form complexes with macrophage proteins. Mol Cell Biol (1996) 1.30
Genetic control of host resistance to infection. Trends Genet (1994) 1.30
Genetic aspects of innate resistance and acquired immunity to mycobacteria in inbred mice. Springer Semin Immunopathol (1988) 1.29
Genetic control of natural resistance in mouse macrophages regulating intracellular Legionella pneumophila multiplication in vitro. Infect Immun (1991) 1.29
The incidence of cancer of the oesophagus in West Kenya. Br J Cancer (1969) 1.29
Immunoglobulin synthesis and lymphocyte transformation by anti-immunoglobulin sera in bursectomized chickens. Immunology (1969) 1.29
Phenotypic expression of genetically controlled host resistance to Listeria monocytogenes. Infect Immun (1979) 1.28
Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani. Infect Immun (1999) 1.27
Genetically determined differences in antibacterial activity of macrophages are expressed in the environment in which the macrophage precursors mature. Cell Immunol (1980) 1.27
Defective stimulus-response coupling in human monocytes infected with Leishmania donovani is associated with altered activation and translocation of protein kinase C. Proc Natl Acad Sci U S A (1992) 1.26
Phosphatidylinositol 3-kinase-dependent activation of protein kinase C-zeta in bacterial lipopolysaccharide-treated human monocytes. J Biol Chem (1997) 1.26
In vitro and in vivo T cell responses in mice during bronchopulmonary infection with mucoid Pseudomonas aeruginosa. Clin Exp Immunol (1995) 1.26
Interleukin 2 deficiency in murine Leishmaniasis donovani and its relationship to depressed spleen cell responses to phytohemagglutinin. J Immunol (1983) 1.25
Stimulus-response coupling in monocytes infected with Leishmania. Attenuation of calcium transients is related to defective agonist-induced accumulation of inositol phosphates. J Immunol (1992) 1.25
A murine macrophage cell line, immortalized by v-raf and v-myc oncogenes, exhibits normal macrophage functions. Eur J Immunol (1987) 1.25
In vivo regulation of nitric oxide production by tumor necrosis factor alpha and gamma interferon, but not by interleukin-4, during blood stage malaria in mice. Infect Immun (1996) 1.24
Genetic resistance/susceptibility to mycobacteria: phenotypic expression in bone marrow derived macrophage lines. J Leukoc Biol (1991) 1.24
Mapping of genetic modulators of natural resistance to infection with Salmonella typhimurium in wild-derived mice. Genomics (1998) 1.24
Linkage analysis of the Bcg gene on mouse chromosome 1. Identification of a tightly linked marker. J Immunol (1989) 1.23
Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guérin involves class II transactivator and depends on the Nramp1 gene. J Immunol (1999) 1.23
Genetic control of blood parasitaemia in mouse malaria maps to chromosome 8. Nat Genet (1997) 1.22
Polymorphism in the 3'-untranslated region of TNFalpha mRNA impairs binding of the post-transcriptional regulatory protein HuR to TNFalpha mRNA. Nucleic Acids Res (2001) 1.22
Killing of Mycobacterium smegmatis by macrophages from genetically susceptible and resistant mice. J Leukoc Biol (1990) 1.22
Monoclonal antibodies to E92, an endothelial cell surface antigen. Arteriosclerosis (1983) 1.21
Identification of a new malaria susceptibility locus (Char4) in recombinant congenic strains of mice. Proc Natl Acad Sci U S A (2001) 1.21
Nitric oxide expression in the spleen, but not in the liver, correlates with resistance to blood-stage malaria in mice. J Immunol (1995) 1.20
Lymphocyte transformation by H-chain specific anti-immunoglobulin sera. Nature (1969) 1.20
Host-parasite relationship in murine leishmaniasis: pathophysiological and immunological changes. Infect Immun (1982) 1.20
Control of the Bcg gene of early resistance in mice to infections with BCG substrains and atypical mycobacteria. Clin Exp Immunol (1986) 1.19
Enhanced resistance to Listeria monocytogenes in splenectomized mice. Immunology (1977) 1.19